Pharmaceutical…
≥ 99.5%
Pharmaceutical Intermediates
5-Bromo-2-chlorobenzoic Acid
High-purity halogenated benzoic acid derivative used as a key building block in SGLT2 inhibitor antidiabetic synthesis.
- CAS Number
- 21739-92-4
- Molecular Formula
- C7H4BrClO2
- Molecular Weight
- 235.46 g/mol
- Therapeutic Category
- Empagliflozin Intermediate
- Purity
- ≥ 99.0%
- Grade
- IP / BP / USP / EP
- Appearance
- White to off-white crystalline powder
- Solubility
- Soluble in common organic solvents (Methanol, DMF, Ethanol)
- Storage
- Store below 25 °C in a tightly closed container, protected from light and moisture
- Packaging
- 25 kg HDPE drum with double LDPE inner liner / Glass carboys
Product Overview
High-purity halogenated benzoic acid derivative used as a key building block in SGLT2 inhibitor antidiabetic synthesis.
Manufactured at Harvinlabs WHO-GMP certified facility under strict quality control standards. Supplied with batch-specific Certificate of Analysis (CoA), HPLC/GC purity reports, and full regulatory documentation.
Applications
- Empagliflozin Synthesis
- SGLT2 Inhibitor API Intermediate
- Halogenated Fine Chemical Synthesis
Specifications
| Parameter | Specification |
|---|---|
| Appearance | White crystalline powder |
| Identification | Complies by IR and HPLC/GC |
| Purity (Assay) | ≥ 99.0% |
| Single Impurity | NMT 0.10% |
| Loss on Drying | NMT 0.5% |
| Residue on Ignition | NMT 0.1% |
| Heavy Metals | NMT 10 ppm |
Need bulk quantities or documentation?
Our regulatory team supplies DMF, COA, MSDS and stability data on request.
Related Products
5-Bromo-2-chlorobenzoic Acid
CAS 21739-92-4